Techniques for molecular imaging probe design

Molecular Imaging

Volumn 10, Issue 6, 2011, Pages 407-419

  Reynolds, Fred ^a   Kelly, Kimberly A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCERTED EFFORT; GENOMICS; MATERIAL SCIENCE; MOLECULAR IMAGING; PROTEOMICS; SCREENING TECHNIQUES; TARGET SELECTION; TARGETED IMAGING; UNDERLYING MECHANISM;

DISEASES; MOLECULAR BIOLOGY; PATIENT TREATMENT; PROBES;

DIAGNOSIS;

ANTIBODY; DNA; PEPTIDE; RNA;

ANIMAL; CHEMISTRY; GENETIC PROCEDURES; HUMAN; METHODOLOGY; MOLECULAR IMAGING; MOLECULAR PROBE; REVIEW;

ANIMALS; ANTIBODIES; DNA; HUMANS; MOLECULAR IMAGING; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; PEPTIDES; RNA;

EID: 84855322440     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00003     Document Type: Article

References (165)

1. Reile H, Armatis PE, Schally AV. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells. Prostate 1994;25:29-38. (Pubitemid 24230912)
2. De Vincentis G, Remediani S, Varvarigou AD, et al. Role of 99mTc-bombesin scan in diagnosis and staging of prostate cancer. Cancer Biother Radiopharm 2004;19:81-4. (Pubitemid 38401047)
3. Zhang H, Schuhmacher J, Waser B, et al. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptorpositive tumours. Eur J Nucl Med Mol Imaging 2007;34:1198-208. (Pubitemid 47296770)
4. Kelly KA, Nahrendorf M, Yu AM, et al. In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol 2006;8:201-7. (Pubitemid 44193415)
5. Kelly KA, Bardeesy N, Anbazhagan R, et al. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med 2008;5:e85.
6. Newton JR, Kelly KA, Mahmood U, et al. In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia 2006;8:772-80. (Pubitemid 44465528)
7. Kelly KA, Shaw SY, Nahrendorf M, et al. Unbiased discovery of in vivo imaging probes through in vitro profiling of nanoparticle libraries. Integr Biol (Camb) 2009;1:311-7.
8. Kelly K, Alencar H, Funovics M, et al. Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res 2004;64:6247-51. (Pubitemid 39129427)
9. Coy DH, Heinz-Erian P, Jiang NY, et al. Progress in the development of competitive bombesin antagonists. Ann N Y Acad Sci 1988;547:150-7.
10. Gargosky SE, Wallace JC, Upton FM, Ballard FJ. C-terminal bombesin sequence requirements for binding and effects on protein synthesis in Swiss 3T3 cells. Biochem J 1987;247:427-32. (Pubitemid 17153347)
11. Geng JG, Heavner GA, McEver RP. Lectin domain peptides from selectins interact with both cell surface ligands and Ca2+ ions. J Biol Chem 1992;267:19846-53.
12. Reynolds PR, Larkman DJ, Haskard DO, et al. Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 2006;241:469-76. (Pubitemid 44632893)
13. Smith GP, Petrenko VA. Phage display. Chem Rev 1997;97:391-410. (Pubitemid 127659250)
14. Geysen HM, Meloen RH, Barteling SJ. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A 1984;81:3998-4002. (Pubitemid 14054511)
15. Maeji NJ, Bray AM, Geysen HM. Multi-pin peptide synthesis strategy for T cell determinant analysis. J Immunol Methods 1990;134:23-33. (Pubitemid 20350984)
16. Houghten RA, Pinilla C, Blondelle SE, et al. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 1991;354:84-6. (Pubitemid 21896788)
17. Falsey JR, Renil M, Park S, et al. Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjug Chem 2001;12:346-53. (Pubitemid 32464180)
18. Fodor SP, Read JL, Pirrung MC, et al. Light-directed, spatially addressable parallel chemical synthesis. Science 1991;251:767-73. (Pubitemid 21926165)
19. Songyang Z, Margolis B, Chaudhuri M, et al. The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif. J Biol Chem 1995;270:14863-6.
20. Lam KS, Zhao ZG. Targeted therapy for lymphoma with peptides. Hematol Oncol Clin North Am 1997;11:1007-19. (Pubitemid 27431159)
21. Kumaresan PR, Lam KS. Screening chemical microarrays: methods and applications. Mol Biosyst 2006;2:259-70. (Pubitemid 43965638)
22. Lam KS, Salmon SE, Hersh EM, et al. A new type of synthetic peptide library for identifying ligand-binding activity. Nature 1991;354:82-4. (Pubitemid 21896787)
23. Lam KS, Lebl M, Krchnak V, et al. Discovery of D-amino-acidcontaining ligands with selectide technology. Gene 1993;137:13-6. (Pubitemid 24053726)
24. Aina OH, Sroka TC, Chen ML, Lam KS. Therapeutic cancer targeting peptides. Biopolymers 2002;66:184-99. (Pubitemid 35285218)
25. Cull MG, Miller JF, Schatz PJ. Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A 1992;89:1865-9.
26. Mattheakis LC, Bhatt RR, Dower WJ. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc Natl Acad Sci U S A 1994;91:9022-6.
27. Mattheakis LC, Dias JM, Dower WJ. Cell-free synthesis of peptide libraries displayed on polysomes. Methods Enzymol 1996;267:195-207.
28. Peelle BR, Krauland EM, Wittrup KD, Belcher AM. Design criteria for engineering inorganic material-specific peptides. Langmuir 2005;21:6929-33. (Pubitemid 41084481)
29. Krauland EM, Peelle BR, Wittrup KD, Belcher AM. Peptide tags for enhanced cellular and protein adhesion to single-crystalline sapphire. Biotechnol Bioeng 2007;97:1009-20. (Pubitemid 47195299)
30. Silverman AP, Levin AM, Lahti JL, Cochran JR. Engineered cystine-knot peptides that bind alpha (v) beta (3) integrin with antibody-like affinities. J Mol Biol 2009;385:1064-75.
31. Giebel LB, Cass RT, Milligan DL, et al. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry 1995;34:15430-5.
32. Devlin JJ, Panganiban LC, Devlin PE. Random peptide libraries: a source of specific protein binding molecules. Science 1990;249:404-6.
33. Katz BA. Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence. Biochemistry 1995;34:15421-9.
34. Katz BA. Streptavidin-binding and-dimerizing ligands discovered by phage display, topochemistry, and structure-based design. Biomol Eng 1999;16:57-65. (Pubitemid 30184839)
35. Katz BA, Johnson C, Cass RT. Structure-based design of high affinity streptavidin binding cyclic peptide ligands containing thioether crosslinks. J Am Chem Soc 1995;117:8541-7.
36. Avrantinis SK, Stafford RL, Tian X, Weiss GA. Dissecting the streptavidin-biotin interaction by phage-displayed shotgun scanning. Chembiochem 2002;3:1229-34. (Pubitemid 36005315)
37. Meyer SC, Gaj T, Ghosh I. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display. Chem Biol Drug Des 2006;68:3-10. (Pubitemid 44272813)
38. Lunder M, Bratkovic T, Doljak B, et al. Comparison of bacterial and phage display peptide libraries in search of target-binding motif. Appl Biochem Biotechnol 2005;127:125-31. (Pubitemid 41567070)
39. Kelly KA, Carson J, McCarthy JR, Weissleder R. Novel peptide sequence ("IQ-tag") with high affinity for NIR fluorochromes allows protein and cell specific labeling for in vivo imaging. PLoS One 2007;2:e665.
40. Romanov VI, Durand DB, Petrenko VA. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 2001;47:239-51. (Pubitemid 32521743)
41. Zitzmann S, Mier W, Schad A, et al. A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin Cancer Res 2005;11:139-46. (Pubitemid 40075788)
42. Zitzmann S, Kramer S, Mier W, et al. Identification and evaluation of a new tumor cell-binding peptide, FROP-1. J Nucl Med 2007;48:965-72. (Pubitemid 46909925)
43. Pola R, Pechar M, Ulbrich K, Fres AF. Polymer doxorubicin conjugate with a synthetic peptide ligand targeted on prostate tumor. J Bioactive Compatible Polymers 2007;22:602-20. (Pubitemid 350145478)
44. Kelly KA, Setlur SR, Ross R, et al. Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res 2008;68:2286-91. (Pubitemid 351521802)
45. Newton-Northup JR, Figueroa SD, Quinn TP, Deutscher SL. Bifunctional phage-based pretargeted imaging of human prostate carcinoma. Nucl Med Biol 2009;36:789-800.
46. Flynn CE, Lee SW, Peelle BR, Belcher AM. Viruses as vehicles for growth, organization, and assembly of materials. Acta Mater 2003;51:5867-80.
47. Seker UO, Wilson B, Dincer S, et al. Adsorption behavior of linear and cyclic genetically engineered platinum binding peptides. Langmuir 2007;23:7895-900. (Pubitemid 47155290)
48. Bassindale AR, Codina-Barrios A, Frascione N, Taylor PG. An improved phage display methodology for inorganic nanoparticle fabrication. Chem Commun (Camb) 2007;28:2956-8. (Pubitemid 47052130)
49. Seker UO, Wilson B, Sahin D, et al. Quantitative affinity of genetically engineered repeating polypeptides to inorganic surfaces. Biomacromolecules 2009;10:250-7.
50. Li Y, Whyburn GP, Huang Y. Specific peptide regulated synthesis of ultrasmall platinum nanocrystals. J Am Chem Soc 2009;131:15998-9.
51. 2 binding peptide. Langmuir 2008;24:6852-7.
52. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996;380:364-6. (Pubitemid 26097120)
53. Kennel SJ, Mirzadeh S, Hurst GB, et al. Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors. Nucl Med Biol 2000;27:815-25. (Pubitemid 32058821)
54. Rafii S, Avecilla ST, Jin DK. Tumor vasculature address book: identification of stage-specific tumor vessel zip codes by phage display. Cancer Cell 2003;4:331-3. (Pubitemid 37491092)
55. Zou J, Dickerson MT, Owen NK, et al. Biodistribution of filamentous phage peptide libraries in mice. Mol Biol Rep 2004;31:121-9. (Pubitemid 38881802)
56. Kolonin MG, Sun J, Do KA, et al. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J 2006;20:979-81.
57. Yu Y, Wang Z, Du T. Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo. J Biomol Screen 2008;13:968-74.
58. Arap W, Kolonin MG, Trepel M, et al. Steps toward mapping the human vasculature by phage display. Nat Med 2002;8:121-7. (Pubitemid 34155122)
59. Tian F, Tsao ML, Schultz PG. A phage display system with unnatural amino acids. J Am Chem Soc 2004;126:15962-3. (Pubitemid 39627597)
60. Sandman KE, Benner JS, Noren CJ. Phage display of selenopeptides. J Am Chem Soc 2000;122:960-1.
61. Tan R, Frankel AD. A novel glutamine-RNA interaction identified by screening libraries in mammalian cells. Proc Natl Acad Sci U S A 1998;95:4247-52. (Pubitemid 28207897)
62. Castagnoli L, Zucconi A, Quondam M, et al. Alternative bacteriophage display systems. Comb Chem High Throughput Screen 2001;4:121-33. (Pubitemid 32410536)
63. Malys N, Chang DY, Baumann RG, et al. A bipartite bacteriophage T4 SOC and HOC randomized peptide display library: detection and analysis of phage T4 terminase (gp17) and late sigma factor (gp55) interaction. J Mol Biol 2002;319:289-304. (Pubitemid 34729458)
64. Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004;3:301-17. (Pubitemid 38499758)
65. De Lano WL, Ultsch MH, de Vos AM, Wells JA. Convergent solutions to binding at a protein-protein interface. Science 2000;287:1279-83. (Pubitemid 30112152)
66. De Ciechi PA, Devine CS, Lee SC, et al. Utilization of multiple phage display libraries for the identification of dissimilar peptide motifs that bind to a B7-1 monoclonal antibody. Mol Divers 1996;1:79-86.
67. Hall PR, Hjelle B, Njus H, et al. Phage display selection of cyclic peptides that inhibit Andes virus infection. J Virol 2009;83:8965-9.
68. Rao WH, Camp RD. Novel cyclic and linear oligopeptides that bind to integrin beta1 chain and either inhibit or costimulate T lymphocytes. Int Immunopharmacol 2003;3:435-43. (Pubitemid 36293972)
69. Noppe W, Plieva F, Galaev IY, et al. Chromato-panning: an efficient new mode of identifying suitable ligands from phage display libraries. BMC Biotechnol 2009;9:21.
70. Dharmasena MN, Jewell DA, Taylor RK. Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry. J Biol Chem 2007;282:33805-16. (Pubitemid 350159528)
71. Kelly KA, Allport JR, Tsourkas A, et al. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005;96:327-36. (Pubitemid 40279907)
72. Wu M, Pasula R, Smith PA, Martin WJN. Mapping alveolar binding sites in vivo using phage peptide libraries. Gene Ther 2003;10:1429-36. (Pubitemid 36987136)
73. Lu Z, Murray KS, Van Cleave V, et al. Expression of thioredoxin random peptide libraries on the E. coli cell surface as functional fusions to flagellin: a system designed for exploring protein protein interactions Nat Biotechnol 1995;13:366.
74. Lu Z, Lavallie ER, McCoy JM. Using biopanning of FLITRX peptide libraries displayed on E. coli cell surface to study protein protein interactions. Methods Mol Biol 2008;205:267.
75. Taschner S, Meinke A, von Gabain A, Boyd AP. Selection of peptide entry motifs by bacterial surface display. Biochem J 2002;367:393-402. (Pubitemid 35216813)
76. Bessette PH, Rice JJ, Daugherty PS. Rapid isolation of highaffinity protein binding peptides using bacterial display. Protein Eng Des Sel 2004;17:731-9. (Pubitemid 40143855)
77. Dane KY, Chan LA, Rice JJ, Daugherty PS. Isolation of cell specific peptide ligands using fluorescent bacterial display libraries. J Immunol Methods 2006;309:120-9. (Pubitemid 43190808)
78. Rice JJ, Schohn A, Bessette PH, et al. Bacterial display using circularly permuted outer membrane protein OmpX yields high affinity peptide ligands. Protein Sci 2006;15:825-36.
79. Kjaergaard K, Schembri MA, Klemm P. Novel Zn (2+)-chelating peptides selected from a fimbria-displayed random peptide library. Appl Environ Microbiol 2001;67:5467-73. (Pubitemid 33640977)
80. Yang Z, Liu Q, Wang Q, Zhang Y. Novel bacterial surface display system based on outer membrane anchoring elements from the marine bacterium Vibro anguillarum. Appl Environ Microbiol 2008;74:4359-65. (Pubitemid 352031017)
81. Zhao S, Lee EY. A protein phosphatase-1-binding motif identified by the panning of a random peptide display library. J Biol Chem 1997;272:28368-72. (Pubitemid 27517782)
82. Xin ZT, Liu C, Gao YP, et al. Identification of mimotopes by screening of a bacterially displayed random peptide library and its use in eliciting an immune response to native HBV-preS. Vaccine 2003;21:4373-9. (Pubitemid 37138702)
83. Brown CK, Modzelewski RA, Johnson CS, Wong MK. A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library. Ann Surg Oncol 2000;7:743-9.
84. Dong J, Liu C, Zhang J, et al. Selection of novel nickel-binding peptides from flagella displayed secondary peptide library. Chem Biol Drug Des 2006;68:107-12. (Pubitemid 44454428)
85. Yang W, Luo D, Wang S, et al. TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Clin Cancer Res 2008;14:5494-502.
86. Hermann T, Patel DJ. Adaptive recognition by nucleic acid aptamers. Science 2000;287:820-5. (Pubitemid 30084318)
87. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346:818-22.
88. Famulok M, Mayer G, Blind M. Nucleic acid aptamers-from selection in vitro to applications in vivo. Acc Chem Res 2000;33:591-9.
89. Eaton BE, Gold L, Hicke BJ, et al. Post-SELEX combinatorial optimization of aptamers. Bioorg Med Chem 1997;5:1087-96. (Pubitemid 27264835)
90. Famulok M. Exploring chemical space with aptamers. J Med Chem 2009;52:6951-7.
91. Bunka DH, Stockley PG. Aptamers come of age-at last. Nat Rev Microbiol 2006;4:588-96.
92. Dougan H, Lyster DM, Vo CV, et al. Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood. Nucl Med Biol 2000;27:289-97. (Pubitemid 30314723)
93. Hicke BJ, Watson SR, Koenig A, et al. DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest 1996;98:2688-92.
94. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-10.
95. Robertson DL, Joyce GF. Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature 1990;344:467-8.
96. Ruckman J, Green LS, Beeson J, et al. 29-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 1998;273:20556-67. (Pubitemid 28377626)
97. Charlton J, Sennello J, Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 1997;4:809-16. (Pubitemid 28000621)
98. Dausse E, Da Rocha Gomes S, Toulme JJ. Aptamers: a new class of oligonucleotides in the drug discovery pipeline? Curr Opin Pharmacol 2009;9:602-7.
99. Patel DJ. Structural analysis of nucleic acid aptamers. Curr Opin Chem Biol 1997;1:32-46. (Pubitemid 127435143)
100. Carothers JM, Oestreich SC, Szostak JW. Aptamers selected for higher-affinity binding are not more specific for the target ligand. J Am Chem Soc 2006;128:7929-37. (Pubitemid 43945734)
101. Tang J, Xie J, Shao N, Yan Y. The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods. Electrophoresis 2006;27:1303-11.
102. Bruno JG, Carrillo MP, Phillips T, et al. Competitive FRET-aptamer-based detection of methylphosphonic acid, a common nerve agent metabolite. J Fluoresc 2008;18:867-76.
103. Gilbert JC, De Feo-Fraulini T, Hutabarat RM, et al. First-inhuman evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers. Circulation 2007;116:2678-86. (Pubitemid 350291240)
104. Majumder P, Gomes KN, Ulrich H. Aptamers: from bench side research towards patented molecules with therapeutic applications. Expert Opin Ther Pat 2009;19:1603-13.
105. Thiel KW, Giangrande PH. Therapeutic applications of DNA and RNA aptamers. Oligonucleotides 2009;19:209-22.
106. Apte RS. Pegaptanib sodium for the treatment of age-related macular degeneration. Expert Opin Pharmacother 2008;9:499-508. (Pubitemid 351291794)
107. Cowperthwaite MC, Ellington AD. Bioinformatic analysis of the contribution of primer sequences to aptamer structures. J Mol Evol 2008;67:95-102.
108. Keefe AD, Cload ST. SELEX with modified nucleotides. Curr Opin Chem Biol 2008;12:448-56.
109. Eulberg D, Klussmann S. Spiegelmers: biostable aptamers. Chembiochem 2003;4:979-83. (Pubitemid 37267585)
110. Lin Y, Qiu Q, Gill SC, Jayasena SD. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res 1994;22:5229-34.
111. Shangguan D, Li Y, Tang Z, et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A 2006;103:11838-43. (Pubitemid 44215773)
112. Xiao Z, Shangguan D, Cao Z, et al. Cell-specific internalization study of an aptamer from whole cell selection. Chemistry 2008;14:1769-75.
113. Mi J, Liu Y, Rabbani ZN, et al. In vivo selection of tumortargeting RNA motifs. Nat Chem Biol 2010;6:22-4.
114. Nicholson RL, Welch M, Ladlow M, Spring DR. Small-molecule screening: advances in microarraying and cell-imaging technologies. ACS Chem Biol 2007;2:24-30. (Pubitemid 47490239)
115. Vegas AJ, Fuller JH, Koehler AN. Small-molecule microarrays as tools in ligand discovery. Chem Soc Rev 2008;37:1385-94.
116. Sun YS, Landry JP, Fei YY, et al. Macromolecular scaffolds for immobilizing small molecule microarrays in label-free detection of protein-ligand interactions on solid support. Anal Chem 2009;81:5373-80.
117. MacBeath G, Koehler AN, Schreiber SL. Printing small molecules as microarrays and detecting protein-ligand interactions en masse. J Am Chem Soc 1999;121:7967-8. (Pubitemid 29420532)
118. Hergenrother PJ, Depew KM, Schreiber SL. Small molecule microarrays: covalent attachment and screening of alcoholcontaining small molecules on glass slides. J Am Chem Soc 2000;122:7849-50.
119. Nicholson RL, Ladlow ML, Spring DR. Fluorous tagged small molecule microarrays. Chem Commun (Camb) 2007;38:3906-8. (Pubitemid 351194510)
120. Kohn M, Wacker R, Peters C, et al. Staudinger ligation: a new immobilization strategy for the preparation of small-molecule arrays. Angew Chem Int Ed Engl 2003;42:5830-4. (Pubitemid 38029590)
121. Lee MR, Shin I. Fabrication of chemical microarrays by efficient immobilization of hydrazide-linked substances on epoxide-coated glass surfaces. Angew Chem Int Ed Engl 2005;44:2881-4. (Pubitemid 40689664)
122. Bradner JE, McPherson OM, Mazitschek R, et al. A robust smallmolecule microarray platform for screening cell lysates. Chem Biol 2006;13:493-504. (Pubitemid 43729507)
123. Tort N, Salvador JP, Eritja R, et al. Fluorescence site-encoded DNA addressable hapten microarrays for anabolic androgenic steroids. Trends Anal Chem 2009;26:718-28.
124. Kurosu M, Mowers WA. Small-molecule microarrays: development of novel linkers and an efficient detection method for bound proteins. Bioorg Med Chem Lett 2006;16:3392-5. (Pubitemid 43777100)
125. Pohl NL. Fluorous tags catching on microarrays. Angew Chem Int Ed Engl 2008;47:3868-70.
126. Roska RL, Lama TG, Hennes JP, Carlson RE. Small moleculebased binding environments: combinatorial construction of microarrays for multiplexed affinity screening. J Am Chem Soc 2009;131:16660-2.
127. Marsden DM, Nicholson RL, Ladlow M, Spring DR. 3D smallmolecule microarrays. Chem Commun (Camb) 2009;46:7107-9.
128. Kanoh N, Kyo M, Inamori K, et al. SPR imaging of photo-crosslinked small-molecule arrays on gold. Anal Chem 2006;78:2226-30.
129. Weissleder R, Kelly K, Sun EY, et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 2005;23:1418-23. (Pubitemid 41679395)
130. Sun EY, Josephson L, Kelly KA, Weissleder R. Development of nanoparticle libraries for biosensing. Bioconjug Chem 2006;17:109-13. (Pubitemid 43157591)
131. Brenner S, Lerner RA. Encoded combinatorial chemistry. Proc Natl Acad Sci U S A 1992;89:5381-3.
132. Winssinger N, Ficarro S, Schultz PG, Harris JL. Profiling protein function with small molecule microarrays. Proc Natl Acad Sci U S A 2002;99:11139-44. (Pubitemid 34920892)
133. Clark MA, Acharya RA, Arico-Muendel CC, et al. Design, synthesis and selection of DNA-encoded small-molecule libraries. Nat Chem Biol 2009;5:647-54.
134. Halpin DR, Harbury PB. DNA display I. Sequence-encoded routing of DNA populations. PLoS Biol 2004;2: E173.
135. Wrenn SJ, Weisinger RM, Halpin DR, Harbury PB. Synthetic ligands discovered by in vitro selection. J Am Chem Soc 2007;129:13137-43. (Pubitemid 350058354)
136. Woiwode TF, Haggerty JE, Katz R, et al. Synthetic compound libraries displayed on the surface of encoded bacteriophage. Chem Biol 2003;10:847-58. (Pubitemid 37171902)
137. Yin J, Liu F, Schinke M, et al. Phagemid encoded small molecules for high throughput screening of chemical libraries. J Am Chem Soc 2004;126:13570-1. (Pubitemid 39407209)
138. Norman BH, Srinivasan U, Dodge JA, Sato M. Wortmannin analogs for inhibiting bone loss or resorption. UK patent 2302021. 1997.
139. Yuan H, Luo J, Field S, et al. Synthesis and activity of C11-modified wortmannin probes for PI3 kinase. Bioconjug Chem 2005;16:669-75. (Pubitemid 40696061)
140. Kobayashi H, Ogawa M, Alford R, et al. New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev 2010;110:2620-40.
141. Scott DW, De Groot AS. Can we prevent immunogenicity of human protein drugs? Ann Rheum Dis 2010;69:i72-6.
142. Paik CH, Ebbert MA, Murphy PR, et al. Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride. J Nucl Med 1983;24:1158-63. (Pubitemid 14218712)
143. Wu AM, Olafsen T. Antibodies for molecular imaging of cancer. Cancer J 2008;14:191-7.
144. Carter P, Merchant AM. Engineering antibodies for imaging and therapy. Curr Opin Biotechnol 1997;8:449-54. (Pubitemid 27351282)
145. Han M, Partin AW. Current clinical applications of the Incapromab pendetide scan (ProstaScint (R) Scan, Cyt-356). Rev Urol 2001;3:165-71.
146. Breitz HB, Tyler A, Bjorn MJ, et al. Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy. Clin Nucl Med 1997;22:615-20. (Pubitemid 28049475)
147. Su WT, Brachman M, O'Connell TX. Use of OncoScint scan to assess resectability of hepatic metastases from colorectal cancer. Am Surg 2001;67:1200-3. (Pubitemid 33738192)
148. Ronald JA, Chen JW, Chen Y, et al. Enzyme-sensitive magnetic resonance imaging targeting myeloperoxidase identifies active inflammation in experimental rabbit atherosclerotic plaques. Circulation 2009;120:592-9.
149. Moats RA, Fraser SE, Meade TJ. A "smart" magnetic resonance imaging agent that reports on specific enzymic activity. Angew Chem Int Ed Eng 1997;36:726-8.
150. Rajotte D, Ruoslahti E. Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display. J Biol Chem 1999;274:11593-8.
151. Giordano RJ, Edwards JK, Tuder RM, et al. Combinatorial ligand directed lung targeting. Proc Am Thorac Soc 2009;6:411-8.
152. Sadanandam A, Varney ML, Kinarsky L, et al. Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis. OMICS 2007;11:41-57. (Pubitemid 46608893)
153. Kelly KA, Allport JR, Yu AM, et al. SPARC is a VCAM-1 counterligand that mediates leukocyte transmigration. J Leukoc Biol 2007;81:748-56. (Pubitemid 46393552)
154. Yu J, Smith GP. Affinity maturation of phage-displayed peptide ligands. Methods Enzymol 1996;267:3-27. (Pubitemid 26159213)
155. Dwyer JJ, Dwyer MA, Kossiakoff AA. High affinity RNase S-peptide variants obtained by phage display have a novel "hotspot" of binding energy. Biochemistry 2001;40:13491-500. (Pubitemid 33130777)
156. Landon LA, Zou J, Deutscher SL. Effective combinatorial strategy to increase affinity of carbohydrate binding by peptides. Mol Divers 2004;8:35-50. (Pubitemid 39023954)
157. Kongsted J, Ryde U. An improved method to predict the entropy term with the MM/PBSA approach. J Comput Aided Mol Des 2009;23:63-71.
158. Green L, Waugh S, Binkley JP, et al. Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase. J Mol Biol 1995;247:60-8.
159. Orwig KS, Lassetter MR, Hadden MK, Dix TA. Comparison of N-terminal modifications on neurotensin (8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy. J Med Chem 2009;52:1803-13.
160. Lee S, Xie J, Chen X. Peptides and peptide hormones for molecular imaging and disease diagnosis. Chem Rev 2010;110:3087-111.
161. Mariani G, Bruselli L, Kuwert T, et al. A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 2010;37:1959-85.
162. Saif MW, Tzannou I, Makrilia N, Syrigos K. Role and cost effectiveness of PET/CT in management of patients with cancer. Yale J Biol Med 2010;83:53-65.
163. Tombach B, Reimer P. Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imaging. Curr Med Chem 2005;12:2795-804.
164. Klaassen CD. Casarette & Doull's toxicology. New York: McGraw Hill; 1996.
165. Villaraza AJ, Bumb A, Brechbiel MW. Macromolecules dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 2010;110:2921-59.